After two doses of mRNA vaccine only 41% of 107 tested long-term care home workers tested positive for anti-S IgA and 20% for anti-RBD IgA, with IgA titres significantly lower than COVID-19 convalescent patients at a similar time-point [61]. The gene discussed is CD79A; the disease is COVID-19.